These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

316 related articles for article (PubMed ID: 34148559)

  • 1. Behavioral features in Prader-Willi syndrome (PWS): consensus paper from the International PWS Clinical Trial Consortium.
    Schwartz L; Caixàs A; Dimitropoulos A; Dykens E; Duis J; Einfeld S; Gallagher L; Holland A; Rice L; Roof E; Salehi P; Strong T; Taylor B; Woodcock K
    J Neurodev Disord; 2021 Jun; 13(1):25. PubMed ID: 34148559
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The Prader-Willi syndrome Profile: validation of a new measure of behavioral and emotional problems in Prader-Willi syndrome.
    Dykens EM; Roof E; Hunt-Hawkins H
    Orphanet J Rare Dis; 2024 Feb; 19(1):83. PubMed ID: 38395848
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Caregiver priorities for endpoints to evaluate treatments for Prader-Willi syndrome: a best-worst scaling.
    Tsai JH; Scheimann AO; McCandless SE; Strong TV; Bridges JFP
    J Med Econ; 2018 Dec; 21(12):1230-1237. PubMed ID: 30256699
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The behavioral impact of growth hormone treatment for children and adolescents with Prader-Willi syndrome: a 2-year, controlled study.
    Whitman BY; Myers S; Carrel A; Allen D
    Pediatrics; 2002 Feb; 109(2):E35. PubMed ID: 11826245
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Diagnosis and management of sleep disorders in Prader-Willi syndrome.
    Duis J; Pullen LC; Picone M; Friedman N; Hawkins S; Sannar E; Pfalzer AC; Shelton AR; Singh D; Zee PC; Glaze DG; Revana A
    J Clin Sleep Med; 2022 Jun; 18(6):1687-1696. PubMed ID: 35172921
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Reduced gamma-aminobutyric acid is associated with emotional and behavioral problems in Prader-Willi syndrome.
    Rice LJ; Lagopoulos J; Brammer M; Einfeld SL
    Am J Med Genet B Neuropsychiatr Genet; 2016 Dec; 171(8):1041-1048. PubMed ID: 27338833
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The changing purpose of Prader-Willi syndrome clinical diagnostic criteria and proposed revised criteria.
    Gunay-Aygun M; Schwartz S; Heeger S; O'Riordan MA; Cassidy SB
    Pediatrics; 2001 Nov; 108(5):E92. PubMed ID: 11694676
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Hypomethylation of monoamine oxidase A promoter/exon 1 region is associated with temper outbursts in Prader-Willi syndrome.
    Deest M; Buchholz V; Jahn K; Eberlein C; Bleich S; Frieling H
    J Psychiatr Res; 2022 May; 149():359-366. PubMed ID: 34782122
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Aripiprazole treatment for temper outbursts in Prader-Willi syndrome.
    Deest M; Wieting J; Jakob MM; Deest-Gaubatz S; Groh A; Seifert J; Toto S; Bleich S; Frieling H; Eberlein CK
    Orphanet J Rare Dis; 2022 Aug; 17(1):324. PubMed ID: 36028863
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Suicidality in individuals with Prader-Willi syndrome: a review of registry survey data.
    Peleggi A; Bohonowych J; Strong TV; Schwartz L; Kim SJ
    BMC Psychiatry; 2021 Sep; 21(1):438. PubMed ID: 34488710
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Transcranial direct current stimulation reduces food-craving and measures of hyperphagia behavior in participants with Prader-Willi syndrome.
    Bravo GL; Poje AB; Perissinotti I; Marcondes BF; Villamar MF; Manzardo AM; Luque L; LePage JF; Stafford D; Fregni F; Butler MG
    Am J Med Genet B Neuropsychiatr Genet; 2016 Mar; 171B(2):266-75. PubMed ID: 26590516
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Characteristics and relationship between hyperphagia, anxiety, behavioral challenges and caregiver burden in Prader-Willi syndrome.
    Kayadjanian N; Vrana-Diaz C; Bohonowych J; Strong TV; Morin J; Potvin D; Schwartz L
    PLoS One; 2021; 16(3):e0248739. PubMed ID: 33765021
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Approach to the Patient With Prader-Willi Syndrome.
    Höybye C; Tauber M
    J Clin Endocrinol Metab; 2022 May; 107(6):1698-1705. PubMed ID: 35150573
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Clinical management of behavioral characteristics of Prader-Willi syndrome.
    Ho AY; Dimitropoulos A
    Neuropsychiatr Dis Treat; 2010 May; 6():107-18. PubMed ID: 20505842
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Sertraline as a treatment option for temper outbursts in Prader-Willi syndrome.
    Deest M; Jakob MM; Seifert J; Bleich S; Frieling H; Eberlein C
    Am J Med Genet A; 2021 Mar; 185(3):790-797. PubMed ID: 33369086
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Intranasal Carbetocin Reduces Hyperphagia, Anxiousness, and Distress in Prader-Willi Syndrome: CARE-PWS Phase 3 Trial.
    Roof E; Deal CL; McCandless SE; Cowan RL; Miller JL; Hamilton JK; Roeder ER; McCormack SE; Roshan Lal TR; Abdul-Latif HD; Haqq AM; Obrynba KS; Torchen LC; Vidmar AP; Viskochil DH; Chanoine JP; Lam CKL; Pierce MJ; Williams LL; Bird LM; Butler MG; Jensen DE; Myers SE; Oatman OJ; Baskaran C; Chalmers LJ; Fu C; Alos N; McLean SD; Shah A; Whitman BY; Blumenstein BA; Leonard SF; Ernest JP; Cormier JW; Cotter SP; Ryman DC
    J Clin Endocrinol Metab; 2023 Jun; 108(7):1696-1708. PubMed ID: 36633570
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Transcutaneous vagus nerve stimulation (t-VNS): A novel effective treatment for temper outbursts in adults with Prader-Willi Syndrome indicated by results from a non-blind study.
    Manning KE; Beresford-Webb JA; Aman LCS; Ring HA; Watson PC; Porges SW; Oliver C; Jennings SR; Holland AJ
    PLoS One; 2019; 14(12):e0223750. PubMed ID: 31794560
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Obsessive-compulsive symptoms in Prader-Willi and "Prader-Willi-Like" patients.
    State MW; Dykens EM; Rosner B; Martin A; King BH
    J Am Acad Child Adolesc Psychiatry; 1999 Mar; 38(3):329-34. PubMed ID: 10087695
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Clinical Trials in Prader-Willi Syndrome: A Review.
    Mahmoud R; Kimonis V; Butler MG
    Int J Mol Sci; 2023 Jan; 24(3):. PubMed ID: 36768472
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Behavioural change in Prader-Willi syndrome during COVID-19 pandemic.
    Wieting J; Eberlein C; Bleich S; Frieling H; Deest M
    J Intellect Disabil Res; 2021 Jul; 65(7):609-616. PubMed ID: 33754414
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 16.